Literature DB >> 32100188

Left-sided infective endocarditis in persons who inject drugs.

Glen Huang1, Kyle A Davis2, S Allan Petty3, Walter A Tan4,3, Erin W Barnes4,5, James E Peacock4,5.   

Abstract

PURPOSE: The purpose of this study was to describe left-sided infective endocarditis (LSIE) in persons who inject drugs (PWID) and compare that group to PWID with non-LSIE and to non-PWID with LSIE.
METHODS: Retrospective single-center study of adult IE patients from 2011 to 2018.
RESULTS: Of the 333 patients in our cohort, 54 were PWID with LSIE, 75 were PWID with non-LSIE, and 204 were non-PWID with LSIE. When comparing LSIE vs non-LSIE in PWID, the LSIE group was older (median age 35 vs 28.5, p < 0.01), had fewer S. aureus infections (59% vs 92%, p < 0.01), was more likely to have cardiac surgery (31% vs 13%, p < 0.01), and had a higher 10-week mortality (22% vs 5%, p < 0.01). When comparing PWID with LSIE to non-PWID with LSIE, the PWID group were younger (median age 35 vs 46, p < 0.01); had more frequent multi-valve involvement (33% vs 19%, p = 0.04), Staphylococcus aureus infections (54% vs 27%, p < 0.01), and previous IE (24% vs 8%, p < 0.01); and experienced more strokes (54% vs 31%, p < 0.01). Ten-week mortality was similar for LSIE in both PWID and non-PWID (24% vs 20%, p = 0.47).
CONCLUSIONS: LSIE in PWID is not uncommon. Compared to non-LSIE in PWID, valve surgery is more common and mortality is higher. For reasons that are unclear, stroke is more frequent in LSIE in PWID than in non-PWID with LSIE but mortality is no different.

Entities:  

Keywords:  Bacteremia; Endocarditis; Injection drug use; Persons who inject drugs; Valvular disease

Year:  2020        PMID: 32100188     DOI: 10.1007/s15010-020-01402-x

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  1 in total

1.  Temporal Trends of Infective Endocarditis in North America From 2000 to 2017-A Systematic Review.

Authors:  Khawaja M Talha; Mark J Dayer; Martin H Thornhill; Wajeeha Tariq; Verda Arshad; Imad M Tleyjeh; Kent R Bailey; Raj Palraj; Nandan S Anavekar; M Rizwan Sohail; Daniel C DeSimone; Larry M Baddour
Journal:  Open Forum Infect Dis       Date:  2021-09-25       Impact factor: 4.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.